Finanzwire Finanzwire
Basculer en Français
10706 Companies
229174 Keywords
157826 Articles
121734 Press releases
Headlines Articles Press releases ActiTrexx GmbH Remove
  1. Home
  2. Companies
  3. ActiTrexx GmbH
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/20/2025 at 10:05, 8 months 22 days ago

    ActiTrexx Completes Final Patient Treatment in GvHD Therapy Study

    Clinical Study Graft-versus-Host Disease Actileucel Immune Therapy Regulatory T Cells
  • PRESS RELEASE

    published on 10/20/2025 at 10:00, 8 months 22 days ago

    ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease

    ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease. Phase Ib/II study evaluates Actileucel for GvHD prevention
    ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel Phase Ib/II Study
    Logo of ActiTrexx GmbH
  • BRIEF

    published on 03/19/2024 at 10:05, 2 years 3 months ago

    ActiTrexx Initiates Treatment in Graft-versus-Host Disease Study with Novel T Cell Therapy

    Clinical Study ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel
  • PRESS RELEASE

    published on 03/19/2024 at 10:00, 2 years 3 months ago

    ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease

    ActiTrexx GmbH treats first patient with novel regulatory T cell therapy for Graft-versus-Host Disease. Phase Ib/II study evaluates safety and feasibility of Actileucel treatment
    Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel ActiTrexx GmbH Phase Ib/II Study
    Logo of ActiTrexx GmbH
Accesswire
  • Published on 07/11/2026 at 02:50, 1 day 4 hours ago

    Alaska Energy Metals Reports on At-the-Market Equity Financing Program

  • Published on 07/11/2026 at 02:00, 1 day 5 hours ago

    Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancing Te

  • Published on 07/11/2026 at 02:00, 1 day 5 hours ago

    Discovery Energy Metals Announces Non-Brokered Private Placement Financing

  • Published on 07/11/2026 at 00:00, 1 day 7 hours ago

    Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API

  • Published on 07/11/2026 at 00:00, 1 day 7 hours ago

    LNG Energy Group Provides Operational Update

View all ACCESSWIRE
EQS Group
  • Published on 07/11/2026 at 04:00, 1 day 3 hours ago

    CUHK Achieves Top 20 Global Ranking in QS World University Rankings 2027

  • Published on 07/10/2026 at 18:50, 1 day 12 hours ago

    NNS acquires shares in OCI

  • Published on 07/10/2026 at 18:40, 1 day 13 hours ago

    AFX Surpasses $1.1 Billion in Total Trading Volume, Highlighting Capital Efficiency in On-Chain Derivatives

  • Published on 07/10/2026 at 17:45, 1 day 14 hours ago

    WYF Launches Global AI Talent Compact at AI for Good Global Summit 2026

  • Published on 07/10/2026 at 17:14, 1 day 14 hours ago

    Form 8.3 - SAFESTAY PLC: Opening Position Disclosure

View all EQS
Les Echos
  • Published on 07/10/2026 at 18:00, 1 day 13 hours ago

    Half-year liquidity contract statement for CEGEDIM

  • Published on 07/10/2026 at 17:45, 1 day 14 hours ago

    Half-year liquidity contract statement

  • Published on 07/10/2026 at 17:45, 1 day 14 hours ago

    HALF-YEAR LIQUIDITY CONTRACT STATEMENT

  • Published on 07/10/2026 at 10:34, 1 day 21 hours ago

    Number of shares and voting rights - June 2026 (In French only)

  • Published on 07/09/2026 at 18:00, 2 days 13 hours ago

    Second-quarter 2026 activity: +7% (vs. Q2 2025)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy